BATF3 and metabolic syndrome: Our data suggest that deficiency of the transcription factor BATF3 results in phenotypical changes of IgA-coating of bacteria, microbial dysbiosis, and impairs intestinal epithelial barrier function, leading to low-grade inflammation that contributes to the development of metabolic syndrome.